[EN] AMINOHETEROARYL COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS [FR] COMPOSES AMINOHETEROARYLES EN TANT QU'INHIBITEURS DES PROTEINES TYROSINE KINASES
[EN] AMINOHETEROARYL COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS [FR] COMPOSES AMINOHETEROARYLES EN TANT QU'INHIBITEURS DES PROTEINES TYROSINE KINASES
6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS c-MET INHIBITORS
申请人:Nemecek Conception
公开号:US20100273793A1
公开(公告)日:2010-10-28
The disclosure relates to compounds of formula (I):
wherein A, W, R, R
5
, and R
6
are as defined in the disclosure, or a salt thereof, and to their use as drugs, in particular as c-Met inhibitors.
Aminoheteroaryl compounds as protein kinase inhibitors
申请人:Cui Jean Jingrong
公开号:US20060178374A1
公开(公告)日:2006-08-10
Aminoheteroaryl compounds are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.
AMINOHETEROARYL COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
申请人:Pfizer, Inc.
公开号:EP1786777A1
公开(公告)日:2007-05-23
PHARMACEUTICAL COMPOUNDS
申请人:Piramed Limited
公开号:EP1812446A1
公开(公告)日:2007-08-01
DERIVES DE 6-ARYL/HETER0ALKYL0XY BENZOTHIAZOLE ET BENZIMIDAZOLE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE CMET